Adrenergic receptors in the veins of the dog.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects; D003042:Cocaine / Q000494:pharmacology; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology*; D018492:Dopamine Antagonists; D004357:Drug Synergism; D004837:Epinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004878:Ergotamine / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D012501:Saphenous Vein / Q000187:drug effects
D018492:Dopamine Antagonists; D004983:Ethanolamines; D010643:Phenoxybenzamine; D012110:Reserpine; D003042:Cocaine; D007545:Isoproterenol; D004878:Ergotamine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine